160 related articles for article (PubMed ID: 7991260)
21. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
[TBL] [Abstract][Full Text] [Related]
22. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
[TBL] [Abstract][Full Text] [Related]
23. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia.
Castellanos PF; Gates GA; Esselman G; Song F; Vannier MW; Kuo M
Laryngoscope; 1994 Jun; 104(6 Pt 1):656-62. PubMed ID: 8196438
[TBL] [Abstract][Full Text] [Related]
24. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
26. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
[TBL] [Abstract][Full Text] [Related]
27. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
Inagi K; Ford CN; Bless DM; Heisey D
J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
[TBL] [Abstract][Full Text] [Related]
28. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
[TBL] [Abstract][Full Text] [Related]
29. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
Murry T; Woodson GE
J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of spasmodic dysphonia with botulinum toxin].
Vilkman E; Laurikainen E; Marttila R
Duodecim; 1995; 111(16):1546-51. PubMed ID: 9273263
[No Abstract] [Full Text] [Related]
31. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
32. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle.
George EF; Zimbler M; Wu BL; Biller HF; Sanders I
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):888-92. PubMed ID: 1444095
[TBL] [Abstract][Full Text] [Related]
33. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
Langeveld TP; Drost HA; Baatenburg de Jong RJ
Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
[TBL] [Abstract][Full Text] [Related]
34. A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.
Zwirner P; Murry T; Woodson GE
Eur Arch Otorhinolaryngol; 1993; 250(5):271-6. PubMed ID: 8217128
[TBL] [Abstract][Full Text] [Related]
35. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
Witsell DL; Weissler MC; Donovan MK; Howard JF; Martinkosky SJ
Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
[TBL] [Abstract][Full Text] [Related]
36. Spasmodic dysphonia and laryngeal botulinum toxin injection.
Smith ME
West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914
[No Abstract] [Full Text] [Related]
37. Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.
Upile T; Elmiyeh B; Jerjes W; Prasad V; Kafas P; Abiola J; Youl B; Epstein R; Hopper C; Sudhoff H; Rubin J
Head Face Med; 2009 Oct; 5():20. PubMed ID: 19852852
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin treatment for spasmodic dysphonia.
Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
[TBL] [Abstract][Full Text] [Related]
39. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
[TBL] [Abstract][Full Text] [Related]
40. [Spasmodic dysphonia. Investigation and therapeutic methods].
Marion MH; Klap P; Perrin A; Elbaz E
Rev Neurol (Paris); 1992; 148(3):180-3. PubMed ID: 1604131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
